Millions of people suffer from eye and vision-related problems. For some, the solution is as simple as wearing prescription eyeglasses or contact lenses. However, others face challenges that aren’t as easy to rectify. That’s where Lumenis comes into play.
As a world leader in minimally invasive clinical solutions for both ophthalmology and aesthetic markets, it’s making a significant difference. Not only does Lumenis develop advanced energy-based technologies, but it also commercializes them.
The company continues to find innovative solutions. However, it’s already provided the fields of ophthalmology and aesthetic with remarkable technologies. OptiLight is just one example.
The company invented the first and only technology to treat individuals for dry eye disease caused by MGD. Not only is it approved by the Food and Drug Administration (FDA) but also patented. Optimal Pulse Technology (OPT) makes it easier to successfully manage this particular eye disease. Overall, OptiLight is safe, precise, comfortable, and effective.
According to recent statistics, roughly 22% of the U.S. population suffers from dry eye disease along with MGD. That combination leads to an array of uncomfortable symptoms.
Dry eye occurs when a person’s eyes don’t produce adequate tears to keep them lubricated or when tears don’t work the way they should. MGD is a condition that affects the small glands in the eyelid responsible for making the oil layer for tears.
Having to deal with one of these problems is bad enough. However, living with both can prove debilitating for some people. Thanks to OptiLight, people with the two conditions get much-needed relief. Here are the ways this advanced technology helps:
Reduces inflammatory mediators, which, thereby, prevents inflammation
Improves tear breakup time that, in response, decreases osmolarity
Alleviates abnormal blood vessels that commonly cause inflammation
Restores meibomian glands so they function properly
Decreases demodex mites that cause infection and the accumulation of bacteria on the eyelids
As part of this revolutionary system, ophthalmologists and optometrists can select different devices based on their needs.
Patented OPT Handpiece
Not two people have identical faces. Even among twins, facial contours differ, even if slightly. To ensure excellent results, this handpiece allows ophthalmologists and optometrists to customize treatments to cover every curve.
Ergonomic IPL Handpiece
To treat a broader area, Lumenis recommends this option. Patented with SapphireCool technology, it breaks the cycle of inflammation associated with dry eye disease caused by MGD.
For maximum energy control, the Opti-Tip focuses light energy on more delicate areas. As with the other Lumenis devices, it’s safe and effective. At the same time, the Opti-Tip is 100% hygienic.
OptiLight utilizes embedded settings that adhere to strict protocols, making it safe and effective tool.
Additionally, they use Optimal Pulse Technology (OPT), which transforms light-based therapy. As a result, ophthalmologists and optometrists can treat the eyes with absolute precision and control. That’s because while this technology provides optimal energy, it never has spike inconsistencies.
Doctors can treat a patient in just 15 minutes. Specifically for dry eye disease with MGD, it provides an improvement in just four sessions.
Lumenis dedicated years to develop OptiLight. Now, eye doctors can incorporate a system into their practice to provide better patient care.